Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.98 GBX | +4.21% | +25.71% | -70.45% |
10/05 | Shield Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
30/04 | EARNINGS AND TRADING: Software Circle & Beximco report higher revenue | AN |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.45% | 18.65M | |
+5.50% | 111B | |
+11.01% | 105B | |
-12.26% | 22.34B | |
-3.11% | 21.93B | |
-6.13% | 18.59B | |
-36.52% | 18.12B | |
-9.51% | 16.96B | |
+2.91% | 13.7B | |
+37.46% | 12.45B |
- Stock Market
- Equities
- STX Stock
- News Shield Therapeutics plc
- Transcript : Shield Therapeutics plc, 2023 Sales/ Trading Statement Call, Feb 22, 2024